Physician profile
Vipin Malik
NPI 1669413860
$243.01
in general payments reported to CMS, 2019-2025
9 companies · $47.66 in 2025
The $47.66 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.15 · 2020: $39.45 · 2021: $20.50 · 2022: $121 · 2025: $47.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3b Medical, INC. | $47.66 | 2025 | Luna |
| Harmony Biosciences LLC | $45.10 | 2022 | |
| Glaxosmithkline, LLC. | $37.00 | 2020-2022 | |
| Genzyme Corporation | $23.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.06 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.50 | 2021 | |
| Kaleo, INC. | $19.76 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.15 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipin Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.